Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot has reported significant growth in its laparoscopic, orthopedic, and vascular interventional robotic product lines, with a total order volume exceeding 100 units in 2024. The company achieved remarkable milestones with its Toumai Laparoscopic Surgical Robot, including international expansion and record-setting remote surgeries. The SkyWalker Orthopedic Surgical Robot and R-ONE Vascular Interventional Surgical Robot have also seen global adoption, underscoring the company’s competitive positioning and potential for further market penetration.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a company incorporated in China, focusing on the development and commercialization of medical robotic systems. It specializes in laparoscopic, orthopedic, and vascular interventional robotic products, targeting both domestic and international markets.
YTD Price Performance: 5.57%
Average Trading Volume: 12,031,708
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$10.1B
For a thorough assessment of 2252 stock, go to TipRanks’ Stock Analysis page.
